Clinical Trial of Efficacy and Safety of Raphamin in the Treatment of Coronavirus Disease 2019 in Outpatients

PHASE3CompletedINTERVENTIONAL
Enrollment

771

Participants

Timeline

Start Date

April 29, 2022

Primary Completion Date

August 18, 2023

Study Completion Date

August 18, 2023

Conditions
Coronavirus Disease 2019 (COVID-19)
Interventions
DRUG

Raphamin

Tablet for oral use. The drug is administered not during meals. The tablet should be held in mouth until complete dissolution. On the first day, 8 tablets should be administered using the following regimen: 1 tablet every 30 minutes in the first 2 hours (5 tablets in total within 2 hours), then additionally one tablet 3 times with regular time intervals. From day 2 onwards, 1 tablet taken 3 times daily. The treatment period is 5 days.

DRUG

Placebo

Tablet for oral use. The drug is administered not during meals. The tablet should be held in mouth until complete dissolution. Placebo is administered according to the Raphamin regimen.

Trial Locations (36)

97762

City polyclinic # 74, Saint Petersburg

150040

Central city hospital, Yaroslavl

"LLC Medical Center for Diagnostics and Prevention Plus", Yaroslavl

153025

Ivanovo clinical hospital named after Kuvaevs/Polyclinic #10, Ivanovo

170100

Tver State Medical University, Tver'

190121

"LLC BioTechService", Saint Petersburg

192071

City clinic # 44, Saint Petersburg

193312

City Polyclinic # 25 of the Nevsky District, Saint Petersburg

194156

"LLC Energy of Health", Saint Petersburg

194291

"LLC Strategic medical systems", Saint Petersburg

194356

"Llc Medical Clinic", Saint Petersburg

196143

"LLC Research Center Eco-safety", Saint Petersburg

196158

"JSC North-West Center for Evidence-Based Medicine", Saint Petersburg

"LLC Clinic Zvezdnaya", Saint Petersburg

198207

City Polyclinic # 43, Saint Petersburg

198412

Lomonosov Interdistrict Hospital named after I.N. Yudchenko, Saint Petersburg

199106

City Intercession Hospital, Saint Petersburg

199406

"LLC Meili", Saint Petersburg

308000

Belgorod State National Research University, Department of Hospital Therapy, Belgorod

350063

Kuban State Medical University, Infectious Diseases and Phthisiopulmonology, Krasnodar

355000

"LLC Scientific Medical Center for General Therapy and Pharmacology", Stavropol

357502

"LLC Ultrasound Clinic 4D", Pyatigorsk

390039

Ryazan State Medical University named after Academician I.P. Pavlova, Ryazan

394066

Voronezh Regional Clinical Hospital # 1, Voronezh

410005

"LLC Center for DNA Research", Saratov

410012

Saratov State Medical University named after V. I. Razumovsky, Saratov

420012

Kazan State Medical University, Department of Propedeutics of Internal Diseases named after prof. S.S. Zimnitsky, Kazan'

Kazan State Medical University/Department of Infectious Diseases, Kazan'

440067

Clinical Hospital # 4, Penza

443056

Samara City Hospital # 4, Samara

450008

Bashkir State Medical University, Internal Medicine Department, Ufa

603140

"Clinical hospital RZD-Medicine of the city of Nizhny Novgorod", Nizhny Novgorod

610027

Kirov State Medical University, Hospital Therapy Department, Kirov

614070

"LLC Professor's Clinic", Perm

620137

Central city hospital # 7, Yekaterinburg

630051

City Clinical Hospital # 2, Novosibirsk

Sponsors
All Listed Sponsors
lead

Materia Medica Holding

INDUSTRY

NCT05364671 - Clinical Trial of Efficacy and Safety of Raphamin in the Treatment of Coronavirus Disease 2019 in Outpatients | Biotech Hunter | Biotech Hunter